BIORESTORATIVE THERAPIES, INC. Amortization of Intangible Assets
BIORESTORATIVE THERAPIES, INC. (BRTX) reported Amortization of Intangible Assets of $89.75 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-03-26
- BIORESTORATIVE THERAPIES, INC. amortization of intangible assets for the quarter ending 2023-12-31 was $22.44K, a 18.77% increase year-over-year.
- BIORESTORATIVE THERAPIES, INC. amortization of intangible assets for the quarter ending 2023-09-30 was $22.44K, a 9.96% increase year-over-year.
- BIORESTORATIVE THERAPIES, INC. amortization of intangible assets for the quarter ending 2023-06-30 was $22.44K, a 9.95% increase year-over-year.
- BIORESTORATIVE THERAPIES, INC. amortization of intangible assets for the quarter ending 2023-03-31 was $22.44K, a 20.42% increase year-over-year.
- BIORESTORATIVE THERAPIES, INC. amortization of intangible assets for fiscal 2025 was $89.75K, a 0.00% change from fiscal 2024.
- BIORESTORATIVE THERAPIES, INC. amortization of intangible assets for fiscal 2024 was $89.75K, a 0.00% increase from fiscal 2023.
- BIORESTORATIVE THERAPIES, INC. amortization of intangible assets for fiscal 2023 was $89.75K, a 14.57% increase from fiscal 2022.
- BIORESTORATIVE THERAPIES, INC. amortization of intangible assets for fiscal 2022 was $78.33K, a 5.10% increase from fiscal 2021.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month | Amortization of Intangible Assets 48 month |
|---|---|---|---|---|---|
| 2025-12-31 | $89.75K 10-K · filed 2026-03-26 | ||||
| 2024-12-31 | $89.75K 10-K · filed 2026-03-26 | ||||
| 2023-12-31 | $22.44K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $44.87K derived: sum of 2 quarters · filed 2025-03-28 | $67.31K derived: sum of 3 quarters · filed 2025-03-28 | $89.75K 10-K · filed 2025-03-28 | |
| 2023-09-30 | $22.44K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $44.87K derived: sum of 2 quarters · filed 2023-11-13 | $67.31K 10-Q · filed 2023-11-13 | $86.20K derived: sum of 4 quarters · filed 2024-06-11 | |
| 2023-06-30 | $22.44K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $44.87K 10-Q · filed 2023-08-11 | $63.76K derived: sum of 3 quarters · filed 2024-06-11 | $84.17K derived: sum of 4 quarters · filed 2024-06-11 | |
| 2023-03-31 | $22.44K 10-Q · filed 2023-05-12 | $41.33K derived: sum of 2 quarters · filed 2024-06-11 | $61.73K derived: sum of 3 quarters · filed 2024-06-11 | $82.14K derived: sum of 4 quarters · filed 2024-06-11 | |
| 2022-12-31 | $18.89K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-06-11 | $39.30K derived: sum of 2 quarters · filed 2024-06-11 | $59.70K derived: sum of 3 quarters · filed 2024-06-11 | $78.33K 10-K/A · filed 2024-06-11 | |
| 2022-09-30 | $20.41K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $40.81K derived: sum of 2 quarters · filed 2022-11-14 | $59.44K 10-Q · filed 2022-11-14 | $78.07K derived: sum of 4 quarters · filed 2023-03-27 | |
| 2022-06-30 | $20.41K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $39.04K 10-Q · filed 2022-08-15 | $57.67K derived: sum of 3 quarters · filed 2023-03-27 | ||
| 2022-03-31 | $18.63K 10-Q · filed 2022-05-16 | $37.26K derived: sum of 2 quarters · filed 2023-03-27 | |||
| 2021-12-31 | $18.63K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $74.53K 10-K · filed 2023-03-27 | |||
| 2021-09-30 | $55.90K 10-Q · filed 2021-11-15 | ||||
| 2020-12-31 | $74.90K 10-K · filed 2022-03-30 | ||||
| 2012-12-31 | $17.45K derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-02 | $34.91K derived: sum of 2 quarters · filed 2013-04-02 | $52.36K derived: sum of 3 quarters · filed 2013-04-02 | $52.45K 10-K · filed 2013-04-02 | $52.82K 10-K · filed 2013-04-02 |
| 2012-09-30 | $17.45K 10-Q · filed 2012-11-05 | $34.91K derived: sum of 2 quarters · filed 2012-11-05 | $35.00K 10-Q · filed 2012-11-05 | $35.09K derived: sum of 4 quarters · filed 2013-04-02 | |
| 2012-06-30 | $17.45K 10-Q · filed 2012-08-14 | $17.55K 10-Q · filed 2012-08-14 | $17.64K derived: sum of 3 quarters · filed 2013-04-02 | $17.73K derived: sum of 4 quarters · filed 2013-04-02 | |
| 2012-03-31 | $92.00 derived: 10-K 12 month − 3 quarters · filed 2013-04-02 | $184.00 derived: sum of 2 quarters · filed 2013-04-02 | $276.00 derived: sum of 3 quarters · filed 2013-04-02 | $368.00 derived: sum of 4 quarters · filed 2013-04-02 | |
| 2011-12-31 | $92.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-02 | $184.00 derived: sum of 2 quarters · filed 2013-04-02 | $276.00 derived: sum of 3 quarters · filed 2013-04-02 | $368.00 10-K · filed 2013-04-02 | |
| 2011-09-30 | $92.00 10-Q · filed 2012-11-05 | $184.00 derived: sum of 2 quarters · filed 2012-11-05 | $276.00 10-Q · filed 2012-11-05 | ||
| 2011-06-30 | $92.00 10-Q · filed 2012-08-14 | $184.00 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |